A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors October 6, 2017 Sponsor Bristol-Myers Squibb Protocol Number CV202-103 To Learn More Call (201)-510-0950
